Table 2.
Characteristics of studies included in this meta-analysis.
| First author's name | Year of publication |
Number of patients FNAC/FNNAC |
Number of nodules FNAC/FNNAC |
Histopathological diagnosis FNAC/FNNAC |
Study design | Needle gauge | Mair et al. scoring system [22] | Patient's age and gender |
|---|---|---|---|---|---|---|---|---|
| de Carvalho [10] | 2009 | 260/260 | 520/520 | 58/58 | Prospective | 23 | Yes | 238 females, 22 males, and age of 43.2 ± 12.6 |
| Schoedel [21] | 2008 | 122/122 | 180/180 | 23/23 | Prospective | 25 | No | The ratio of female to male was about 6 : 1, with average age of 57.3 |
| Raghuveer [20] | 2002 | 68/68 | 68/68 | 36/36 | Prospective | 23 or 24 | Yes | — |
| McElvanna [19] | 2009 | 65/65 | 65/65 | 65/65 | Retrospective | 23 | No | 58 females, 7 males, and average age of 49 |
| Tauro [15] | 2012 | 50/50 | 50/50 | 38/38 | Prospective | 23 | No | 47 females, 3 males, and age of 39.16 ± 11.47 |
| Maurya [11] | 2010 | 50/50 | 50/50 | — | Prospective | 23 | Yes | — |
| Kamal [12] | 2002 | 200/200 | 200/200 | — | Prospective | 23 or 24 | Yes | 173 females, 27 males |
| Mahajan and Sharma [8] | 2010 | 50/50 | 50/50 | — | Prospective | — | Yes | — |
| Pinki [13] | 2015 | 100/100 | 100/100 | — | Prospective | 22 | Yes | — |
| Ibrahim [23] | 2012 | 50/50 | 50/50 | — | Prospective | 25 | Yes | — |
| Kashi [24] | 2011 | 302/302 | 302/302 | — | Prospective | 25 | Yes | 289 females, 13 males, and age of 43.83 ± 12.9 |
| Chowhan [25] | 2014 | 200/200 | 200/200 | — | Prospective | 24 | Yes | 26 males, 174 females |
| Torabizadeh [14] | 2008 | 200/200 | 200/200 | — | Prospective | / | Yes | 189 females, 11 males, and age of 43.36 ± 12.3 |
| Kaur [26] | 2014 | 50/50 | 50/50 | — | Prospective | 23 | Yes | — |
| Torres [27] | 2003 | 61/61 | 122/122 | — | Prospective | 22 | Yes | 61 females (100%), age of 49.2 ± 15.3 |
| Ghosh [28] | 2000 | 14/14 | 14/14 | — | Prospective | 23–25 | Yes | — |
FNAC: fine needle aspiration cytology, FNNAC: fine needle nonaspiration cytology, and —: not available.